Remedy Cell
Remedy Cell is a biotechnology company, focused on the development of cell-derived, cell-free secretome therapies for areas of unmet need in fibrotic diseases. Its proprietary platform technology delivers a multi-target, pro-regenerative approach that demonstrated the potential to drive tissue regeneration and disease remission. The company’s lead candidate, RC-0315, for treating Idiopathic Pulmonary Fibrosis (IPF) is designed to modify the disease course and is being evaluated in a Phase Ib clinical study.
